Epigenetic and Cellular Mechanisms Underlying the Pathophysiology of Schizophrenia
Abstract
Schizophrenia is a complex neuropsychiatric disorder whose pathogenesis results from the interplay among genetic, environmental, and molecular factors. Epigenetics elucidates how gene expression is regulated without altering the DNA sequence; through biochemical and structural mechanisms, these epigenetic modifications integrate environmental influences and modulate essential processes such as neurodevelopment, synaptic function, and neurotransmission. Aberrant DNA methylation and histone post-translational modifications dysregulate the transcription of genes critical to the functioning of dopaminergic, glutamatergic, and GABAergic systems. A marked decrease in protein synthesis, coupled with deficiencies in integrative metabolic and signaling pathways—such as PI3K/AKT/mTOR—severely compromises neuronal plasticity, memory consolidation, and learning. Finally, sustained neuroinflammation and hyperactivation of the complement immune system induce pathological synaptic pruning, which is responsible for the excessive elimination of indispensable neuronal connections. Schizophrenia cannot be explained by the isolated failure of a single gene, circuit, or neurotransmitter; rather, it is the direct consequence of a network of interacting genetic, epigenetic, and proteomic alterations. Understanding this biological heterogeneity is crucial, as the integrated study of these pathological mechanisms provides new opportunities for developing therapeutic strategies targeted at the molecular foundations of the disease.